fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ASH 2014: T-cell lymphomas: a challenge for clinicians

Written by | 19 Dec 2014

by Thomas R. Collins: Treating patients with T-cell lymphomas is fraught with challenges, requiring new approaches and sharper diagnosis, said Timothy Illidge, MD, PhD, Professor of Targeted Therapy… read more.

ESMO 2014 Report: FOLFIRI plus cetuximab in patients with liver-limited or non-liverlimited RAS wild-type metastatic disease

Written by | 24 Nov 2014

by Esther Drain:  A sub-group analysis of the CRYSTAL study.  In the CRYSTAL study, adding cetuximab (cet) to first-line chemotherapy (CT) improved clinical outcome in patients (pts) with RAS… read more.

ESMO 2014 Report: Adolescent and young adult cancer patients

Written by | 20 Nov 2014

Engagement of patients and understanding of early death in this group by Denys Wheatley. (1) When and why do teenage and young adult oncology patients die early in… read more.

ESMO 2014 Report: How to integrate genome sequencing data in oncology

Written by | 13 Nov 2014

by Denys Wheatley: Chaired by Atsushi Ohtsu and Jean-Yves Douillard, the first speaker Dr Kato (Japan) addressed the issue of the quest for different mutations in the hope… read more.

ESMO 2014 Report: Precision medicine: Panacea or false dawn?

Written by | 6 Nov 2014

Reports from the European Society for Medical Oncology 2014 Congress in Madrid by Denys Wheatley:  In his talk on Visualising the true spectrum of cancer- will we get… read more.

Bendamustne Lymphoma Case Study

Written by | 4 Nov 2014

Ger Walpole, CNS (Clinical Nurse Specialist), H.Dip Oncology Nursing, BNS(Hons), Sligo Regional Hospital, Sligo.   Dr Andrew Hodgson, MB, BS, BSc (Hons), FRCPI, FFPath, FRCPath.   Written by Karen Mas-Mollinedo… read more.

ESMO 2014 Report: Patients with Hodgkin’s lymphoma have a significantly better outcome if treated within a clinical trial

Written by | 14 Oct 2014

by Denys Wheatley: ESMO  Madrid September 2014: Session on Sunday 28 September (poster).  Dr Moccia and his group in Bellinzona (Switzerland) report on the marked improvement over 30… read more.

Metformin treatment associated with low thyroid hormone

Written by | 1 Oct 2014

by Bruce Sylvester – Researchers report that metformin therapy, a treatment for type 2 diabetes, could induce a lowering thyroid-stimulating hormone (TSH) in patients with underactive thyroids (hypothyroidism)…. read more.

ASCO Report 2014: The evolution of our molecular understanding of Colorectal Cancer

Written by | 4 Sep 2014

What we are doing now, what the future Holds, and how Tumour profiling is just the beginning by Dr Paul Ross, Guy’s & St Thomas’ Hospitals, London.  At… read more.

Press Release: Is Europe putting cancer research at risk?

Written by | 25 Jul 2014

Lugano, Switzerland, 25 July 2014.  The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology professionals, has expressed concern that the proposed EU General… read more.

FDA Highlights: Goserelin helps prevent early menopause caused by breast cancer treatment

Written by | 17 Jul 2014

by Bruce Sylvester – Adding goserelin to standard chemotherapy significantly reduces the risk of early menopause in breast cancer patients, researchers reported in May of 2014 at the… read more.

Press Release: Confident but not controlled: 92% of Irish people with asthma are confident about managing their condition however 48% are deemed ‘uncontrolled’1

Written by | 30 Jun 2014

Pan-European Survey reveals low levels of asthma control in Ireland. Irish respondents are experiencing asthma symptoms nearly 3 days a week. 48% of Irish people with asthma are… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.